Abstract

Hyperhomocysteinemia is recognized as a risk factor for several diseases, including cardiovascular and neurological conditions. Homocysteine (HCys) is a key metabolite involved in the biosynthesis and metabolism of methionine (Met), which plays a pivotal role in the physiological cell's life cycle. The biochemistry of Met is finely regulated by several enzymes that control HCys concentration. Indeed, balanced activity among the enzymes is essential for the cell's well-being, while its malfunction could raise HCys concentration which can lead to the onset of several pathological conditions. The HCys concentration increase seems to be caused mainly by the widely diffused polymorphisms of several enzymes. Nowadays, a blood test can easily detect elevated concentrations of HCys, referred to as Hyperhomocysteinemia (HHCys). Prolonged exposure to this condition can lead to the onset of cardiovascular disease and can lead to the development of atherosclerosis, stroke, inflammatory syndromes like osteoporosis and rheumatism, as well as neuronal pathologies including Alzheimer's and Parkinson's diseases. In this review, we analyzed the literature of several pathological conditions in which the molecular pathways of HHCys are involved. Interestingly, several observations indicate that the calibrated assumption of correct doses of vitamins such as folic acid, vitamin B6, vitamin B12, and betaine may control HHCys-related conditions.

Highlights

  • INTRODUCTIONA high blood level of Homocysteine (HCys) has been regarded, in the last 10 years, as a biomarker of cardiovascular disease as well as a risk factor for many other pathologies, including Alzheimer’s and other dementias [1]

  • A high blood level of Homocysteine (HCys) has been regarded, in the last 10 years, as a biomarker of cardiovascular disease as well as a risk factor for many other pathologies, including Alzheimer’s and other dementias [1].Homocysteine (HCys) is a non-essential amino acid that derives from the biosynthesis and metabolism of methionine (Met)

  • Plasma HCys directly correlated with psoriasis severity according to skin psoriasis area and severity index (PASI) score, whereas it was inversely correlated with plasma folic acid levels, which were lower in psoriasis patients than in the controls and lower than the normal range in 13 of 40 (32.5%) psoriasis patients studied [127]

Read more

Summary

INTRODUCTION

A high blood level of Homocysteine (HCys) has been regarded, in the last 10 years, as a biomarker of cardiovascular disease as well as a risk factor for many other pathologies, including Alzheimer’s and other dementias [1]. Homocysteine (HCys) is a non-essential amino acid that derives from the biosynthesis and metabolism of methionine (Met). Within the Met metabolic pathway, HCys either can be irreversibly degraded to cysteine (Cys) via the trans-sulfuration pathway or re-methylated back to Met. HCys is extremely important for the cell’s homeostasis, its physiological activity is essential to Met, which plays a vital role for the cell’s viability

Hyperhomocysteinemia an Efficient Pharmacological Target
Metabolism of Folate
Catabolism of Choline
Causes of Hyperhomocysteinemia
Cardiovascular Effects of Hyperhomocysteinemia
Effects of the Hyperhomocysteinemia in the Nervous System
Homocysteine Levels and the Risk of Osteoporotic Fracture
Hyperhomocysteinemia and Autoimmune Rheumatic Disease
Hyperhomocysteinemia and Diabetes
Hyperhomocysteinemia and Renal Dysfunctions
Hyperhomocysteinemia in Acoustic and Optical Dysfunctions
Hyperhomocysteinemia and Psoriasis
Findings
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.